J&J Sues in Bid to Halt Medicare Drug Price Negotiations
Johnson & Johnson sued the US government on Tuesday, becoming the latest drugmaker seeking to block a program that gives the Medicare government health insurance plan the power to negotiate lower drug prices.
Reuters Health Information
source https://www.medscape.com/s/viewarticle/994493?src=rss
Reuters Health Information
source https://www.medscape.com/s/viewarticle/994493?src=rss
Comments
Post a Comment